Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity.
Investigators reported that urethral dilation prior to transurethral resection of the prostate for enlarged prostate reduces the incidence of postoperative urethral stricture.